Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 5.1B | 4.9B | 5.1B | 5.0B |
Cost of revenue | 3.0B | 2.9B | 3.1B | 3.1B |
Gross profit | 2.1B | 1.9B | 2.0B | 1.9B |
Operating expense | ||||
Research & development | 612.6M | 642.5M | 650.1M | 600.5M |
Selling general and admin | 843.7M | 841.4M | 1.1B | 834.1M |
Other operating expenses | — | — | — | — |
Operating income | 657.4M | 421.4M | 217.6M | 435.0M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | 14.6M | — | — |
Other income expense | -80.5M | -215.1M | 30.6M | -149.6M |
Pretax income | 556.9M | 191.8M | 234.6M | 273.8M |
Tax provision | 102.2M | 32.4M | -1.4B | 36.3M |
Net income | 454.7M | 159.4M | 1.6B | 237.4M |
Basic EPS | 0.9 | 0.3 | — | 0.5 |
Diluted EPS | 0.9 | 0.3 | — | 0.5 |
Basic average shares | 517.6M | 523.1M | — | 520.6M |
Diluted average shares | 522.7M | 536.6M | — | 534.4M |
EBITDA | 804.7M | 503.6M | 143.8M | 675.5M |
Net income from continuing op. | 454.7M | 159.4M | 1.6B | 237.4M |
Minority interests | 104.7K | 971.3K | 18.0M | 2.2M |
Preferred stock dividends | — | — | — | — |